Impact of switching from neutral protamine hagedorn insulin (NPH) to glargine insulin on glycemic control and clinical outcomes in pediatric patients with type 1 diabetes.
- DOI
- 10.1016/j.rcsop.2025.100612
- Published
- 2025 Jun
- Container
- Exploratory research in clinical and social pharmacy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.rcsop.2025.100612,
title = {Impact of switching from neutral protamine hagedorn insulin (NPH) to glargine insulin on glycemic control and clinical outcomes in pediatric patients with type 1 diabetes.},
author = {Elsheikh HAS and Badi S and Kamal AH and Karar M and Fouad M and Khalid O and Abdullah O and Mamoun S},
year = {2025},
journal = {Exploratory research in clinical and social pharmacy},
doi = {10.1016/j.rcsop.2025.100612},
url = {https://doi.org/10.1016/j.rcsop.2025.100612}
}RIS
TY - JOUR TI - Impact of switching from neutral protamine hagedorn insulin (NPH) to glargine insulin on glycemic control and clinical outcomes in pediatric patients with type 1 diabetes. AU - Elsheikh HAS AU - Badi S AU - Kamal AH AU - Karar M AU - Fouad M AU - Khalid O AU - Abdullah O AU - Mamoun S PY - 2025 JO - Exploratory research in clinical and social pharmacy DO - 10.1016/j.rcsop.2025.100612 UR - https://doi.org/10.1016/j.rcsop.2025.100612 ER -
APA
HAS, E., S, B., AH, K., M, K., M, F., O, K., O, A., & S, M. (2025). Impact of switching from neutral protamine hagedorn insulin (NPH) to glargine insulin on glycemic control and clinical outcomes in pediatric patients with type 1 diabetes.. Exploratory research in clinical and social pharmacy. https://doi.org/10.1016/j.rcsop.2025.100612
Source records
- pubmed · retrieved 2026-09-26T14:55:52.549Z